Citations

1. Gladwin MT, et al. (2004). Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350(9): 886–95.

2. Hirst C, Wang WC (2001). Blood transfusion for preventing stroke in people with sickle cell disease. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

3. Steinberg MH (2008). Sickle cell disease and associated hemoglobinopathies. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 1217–1226. Philadelphia: Saunders Elsevier.

4. Wang WC (2004). Sickle cell anemia and other sickling syndromes. In JP Greer et al., eds., Wintrobe's Clinical Hematology, 11th ed., pp. 1264–1311. Philadelphia: Lippincott Williams and Wilkins.

5. National Heart, Lung, and Blood Institute, National Institutes of Health (2002). The Management of Sickle Cell Disease (NIH Publication No. 02-2117). Available online: http://www.nhlbi.nih.gov/health/prof/blood/sickle/.

6. Goldstein LB, et al. (2006). Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke, 37(6): 1583–1633.

7. American Academy of Pediatrics, et al. (2003, reaffirmed 2007). Policy statement: Eye examination in infants, children, and young adults by pediatricians. Pediatrics, 111(4): 902–907.

8. Committee on Genetics, American Academy of Pediatrics (2002). Health supervision for children with sickle cell disease. Pediatrics, 109(3): 526–535.

Other Works Consulted

• Brawley OW, et al. (2008). National Institutes of Health consensus development conference statement: Hydroxyurea treatment for sickle cell disease. Annals of Internal Medicine, 148(12): 932–938.

• De Montalembert M (2008). Management of sickle cell disease. BMJ, 337(a1397): 626–630.

• Furie B, et al. (2003). Red blood cell disorders. In Clinical Hematology and Oncology: Presentation, Diagnosis, and Treatment, pp. 464–465. Philadelphia: Churchill Livingstone.

• Hillman RS, et al. (2005). Hemoglobinopathies. In Hematology in Clinical Practice, 4th ed., pp. 80–94. New York: McGraw-Hill.

• Hirst C, Owusu-Ofori S (2002). Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database of Systematic Reviews (3). Oxford: Update Software.

• Jones AP, et al. (2001). Hydroxyurea for sickle cell disease. Cochrane Database of Systematic Reviews (2). Oxford: Update Software.

• Lanzkron S, et al. (2008). Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Annals of Internal Medicine, 148(12): 939–955.

• Meremikwu MM (2007). Sickle cell disease, search date August 2006. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.

• Price EA, Schrier SL (2008). Hemoglobinopathies and hemolytic anemias. In DC Dale, DD Federman, eds., ACP Medicine, section 5, chap. 4. Hamilton, ON: BC Decker.